Loading...
Images of Lila Drittanti
(0 from 0 )1
0
0
News
Nautilus Biotech anuncia progresos en el desarrollo de Belerofon
www.europapress.es
Nautilus Biotech ha anunciado hoy la conclusión con éxito de estudios en monos que comparaban el IFN alfa...
Nautilus erreicht ersten Meilenstein des Gemeinschaftsprojekts...
www.ots.at
die ja ein wesentlicher Schritt für die Bestimmung des Profils eines potenziellen
hGH der nächsten Generation darstellt", sagte Dr. Lila Drittanti, Leiterin
Forschung und Entwicklung bei Nautilus. Informationen zu Nautilus Biotech.
Network Profiles
LinkedIn: Lila Drittanti - Senior Partner - MARKETS & LISTING S.A.S. | LinkedInfr.linkedin.com › liladrittanti
Voir le profil de Lila Drittanti sur LinkedIn, le plus grand réseau professionnel mondial. Lila a 13 postes sur son profil. Consultez le profil complet sur LinkedIn et ...
Interests
Lila Drittanti - Patents
www.freshpatents.com
Lila Drittanti patents Recent bibliographic sampling of Lila Drittanti patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Business Profiles
Books & Literature
Revista Medicina - Google Books
books.google.de
pulmonary symptoms of cystic fibrosis using replication- deficient recombinant
adenoviruses.- Manuel Vega, Lila Drittanti, Verónica Masciovecchio, Gabriel Peluffo, Rubén Digiglio, César Garat, Jorge Gabbarini Gene therapy of
autoimmunity in a ...
Revista Medicinabooks.google.com › books
books.google.de
Manuel Vega, Lila Drittanti, Veronica Masciovecchio, Gabriel Peluffo, Ruben Digiglio, Cesar Garat, Jorge Gabbarini 602 • Terapia genica en autoinmunidad en ...
Related Documents
Lila Drittanti - Academia.edu
independent.academia.edu
Academia.edu is a place to share and follow research.
Rational evolution of cytokines for higher stability, the cytokines and ...www.freepatentsonline.com › ...
www.freepatentsonline.com
9, 2002, each to Rene Gantier, Thierry Guyon, Manuel Vega and Lila Drittanti. This application is related to U.S. application Ser. No ,830, filed Jul.
(12) Ulllted States Patent (10) Patent No.: US 7,635,679 B2
content.globalinnovationcommons.org
Turin (IT); Lila Drittanti, Vigneux sur. Siene (FR); Thierry Guyon, Palaiseau. (FR); Gilles Borrelly, Epinay sous. Senart (FR); Barbara Canepa, ...
[PDF] Perfiles de Empresas Extranjeras. - SICyTsicyt.scyt.rec.utn.edu.ar › octubre › adjuntos › Perfiles_empresariales
sicyt.scyt.rec.utn.edu.ar
Oct 15, · Representación: Lila Drittanti. CHILE. Empresa: Ibex Technologies LTDA. Actividad: Localizada en Santiago de Chile Ibex Technologies logro ...
Scientific Publications
Client Request Error
www.sciencedirect.com
Stimulation of calmodulin synthesis in proliferating myoblasts by 1,25-dihydroxy-vitamin D 3. Lila Drittanti, ... of calmodulin synthesis in proliferating ...
Molecular and Cellular Endocrinology | Vol 74, Issue 2, Pages...
www.sciencedirect.com
The online version of Molecular and Cellular Endocrinology at ScienceDirect.com, the world's leading platform for high quality peer-reviewed full-text journals.
Video & Audio
Lila Drittanti - YouTube
www.youtube.com
Teile deine Videos mit Freunden, Verwandten oder der ganzen Welt
Reports & Statements
The interactivity between the CFTR gene and cystic fibrosis would be...
www.nature.com
Original Article
The interactivity between the CFTR gene and cystic fibrosis would ...www.nature.com › genetics in medicine › original article
www.nature.com
Mar 1, · M Veronica Masciovecchio, Jorge Gabbarini, Manuel Vega & Lila Drittanti. Service of Paediatrics, Hospital Int. Gral J. Penna, Bahia, Blanca, ...
Miscellaneous
Lila Drittanti | LinkedIn
www.linkedin.com
View Lila Drittanti's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Lila Drittanti discover inside
Lila Drittanti - Senior Partner - MARKETS & LISTING S.A.S. | LinkedIn
www.linkedin.com
community. Lila has 13 jobs listed on their profile. See the complete profile on
LinkedIn and discover Lila's connections and jobs at similar companies.
Lila Drittanti, Vigneux-Sur-Seine FR - Patent applications
www.patentsencyclopedia.com
Lila Drittanti, Vigneux-Sur-Seine FR Lila Drittanti, Vigneux-Sur-Seine FR
WO A8 - Rational evolution of cytokines for higher...
patents.google.com
Processes and systems for the high throughput directed evolution of peptides and proteins, particularly cytokines that act in complex biological...
[PDF] Cystic fibrosis: gene therapy or preventive gene transfer? |...
www.semanticscholar.org
Semantic Scholar extracted view of
154. In Vivo Study on Stability of Recombinant Adeno-Associated ...cyberleninka.org › article
cyberleninka.org
Nadia Billault,1 Marjorie Flaux,1 Nestor Soria,1 Lila Drittanti NautHusBiotech. Adeno-associated virus vectors (rAAV) are emerging as the election vectors ...
Modified growth hormones by Nautilus Biotech – AU
www.ipaustralia.com.au
Get details on patent AU Modified growth hormones by Nautilus Biotech and more at IP in Australia
Ana Vega - Artistes Art Contemporain - CRAC OCCITANIE à Sète -...
crac.laregion.fr
Ana Vega, Artiste d’Art Contemporain. Retrouvez tous les artistes d’art contemporain en ligne sur crac.laregion.fr
Download C361e Manual - ddgay.comms.ddgay.com › ...
ms.ddgay.com
... Thierry Guyon, Manuel Vega and Lila Drittanti, filed Jun. 15, 2007, which claims priority under 35 U.S.C. §119(e) to U.S. Provisional Feb 29, BEGBIE M E ...
Zen-Bio signs with Nautilus Biotech to identify novel genes involved...
www.drugdiscoveryonline.com
Zen-Bio will combine their adipocyte cell technology with Nautilus’ platform technology in high-throughput directed evolution and viral vector...
ESCUELA ARGENTINO BRASILEÑO DE BIOTECNOLOGIA ESCOLA...
docplayer.es
Lila Drittanti y Manuel Vega Institución: Instituto de Investigaciones Biotecnológicas da la Universidad Nacional de San Martín y Departamento de Biología, ...
El INTI y el interferón cumplen 50 años - ArgenBiowww.argenbio.org › 8840
www.argenbio.org
Dec 5, · Cabe destacar que el presidente y la directora científica de la empresa son dos argentinos, Manuel Vega y Lila Drittanti. "Final de juego" o de ...
NAUTILUS BIOTECH
www.gazettelabo.fr
... Lila DRITTANTI — Directeur de Science & Technologie et Patrick BASSAND — Directeur des Operations. R&D et prestations de service en thérapie génique.
On behalf of the PSWC2007 Co-chairs of the Organising Committee ...businessdocbox.com › Biotech_and_Biomedical › On-behalf-of...
businessdocbox.com
... IN WILDTYPE AND TRANSGENIC IMMUNE-TOLERANT MICE Miranda Van Beers, Arno Kromminga, Wim Jiskoot, Thierry Guyon, Gilles Borrelly, Lila Drittanti, ...
Oral dosage formulations of protease-resistant polypeptides - Patent...
www.patentsencyclopedia.com
Oct 23, · No ,830, to Rene Gantier, Thierry Guyon, Manuel Vega and Lila Drittanti, entitled "RATIONAL EVOLUTION OF CYTOKINES FOR HIGHER ...
Polypeptides d'interferon-gamma modifies et procedes d'utilisation de...
www.semanticscholar.org
G. Borrelly, Lila Drittanti, T. Guyon; Published 2006; Chemistry. Cette invention concerne des polypeptides d'interferon-gamma (IFN-?) modifies et des procedes ...
Research Achievement Awardstudyres.com › Science › Biology › Pharmacology
studyres.com
... IN WILDTYPE AND TRANSGENIC IMMUNE-TOLERANT MICE Miranda Van Beers, Arno Kromminga, Wim Jiskoot, Thierry Guyon, Gilles Borrelly, Lila Drittanti, ...
T148Q - Ll.yugkamen.ru › ...
l.yugkamen.ru
,830, to Rene Gantier, Thierry Guyon, Manuel Vega and Lila Drittanti, entitled “RATIONAL EVOLUTION OF CYTOKINES FOR HIGHER STABILITY, THE ...
SABER COMO - INSTITUTO NACIONAL DE TECNOLOGIA INDUSTRIAL
www.inti.gov.ar
Cabe destacar que el presidente y la directora científica de la empresa son dos argentinos, Manuel Vega y Lila Drittanti. "Final de juego" o de la historia, por ...
Related search requests for Lila Drittanti
| Arno Kromminga Thierry Guyon Gilles Borrelly | Manuel Vega |
People Forename "Lila" (3480) Name "Drittanti" (1) |
sorted by relevance / date